Scientists test new cancer Drug's hidden effects on common pills
NCT ID NCT07223671
Summary
This study aimed to understand how a new cancer drug, repotrectinib, might change the levels of other common medications in the body. It involved 30 healthy adult volunteers who took repotrectinib alongside several probe drugs, including metformin and omeprazole. The main goal was to measure drug interactions to help doctors safely prescribe combinations in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Daytona Beach, Florida, 32117-5116, United States
Conditions
Explore the condition pages connected to this study.